Insulin detemir is associated with less weight gain than NPH insulin, especially in the very obese, when used in basal bolus therapy for patients with type 2 diabetes

被引:0
作者
Raslova, K
Karl, D
Tamer, SC
机构
[1] Metab Ctr, Bratislava, Slovakia
[2] Novo Nordisk AS, DK-2880 Bagsvaerd, Denmark
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
842
引用
收藏
页码:A306 / A306
页数:1
相关论文
empty
未找到相关数据